hemophilia A
MeSH: D006467ORPHA: 988782 Treatments Available
Overview
X-linked disease that has material basis in Factor VIII deficiency, which results in the formation of fibrin deficient clots which makes coagulation much more prolonged
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| fitusiran Orphan Cold Chain | Injection, subcutaneous | FDA Approved | 1 | — |
| marstacimab Orphan Cold Chain | — | FDA Approved (2024) | 1 | — |
Clinical Presentation
Signs and symptoms associated with hemophilia A, sourced from HPO and Orphanet clinical annotations.
Joint swellingArthralgiaReduced factor VIII activityJoint hemorrhageBleeding with minor or no traumaThromboembolismSpontaneous hematomasOral cavity bleedingGastrointestinal hemorrhageAbnormality of the elbowIntramuscular hematomaIntraventricular hemorrhageIntracranial hemorrhageSplenic rupture
Classification & Codes
MeSH Code
D006467Orphanet Code
ORPHA:98878hemophilia A
| MeSH | D006467 |
| Orphanet | ORPHA:98878 |
| Treatments | 2 drug(s) |
| Symptoms on record | 14 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO